Achiko AG engages in developing disruptive diagnostic solutions in Indonesia and internationally. The company's lead product is AptameX, a rapid test that uses DNA aptamers instead of antigens to detect the SARS-CoV-2 virus. It also offers Teman Sehat, a mobile check-in and passport application. In addition, the company provides secure payment solutions for game publishers and application developers to accept various payment methods for digital contents and goods under the Mimopay brand, as well as develops game software. Achiko AG was incorporated in 2018 and is headquartered in Zurich, Switzerland.
Frequently asked questions
What sector does ACHIKO AG SF -01 (4ZI) operate in?
ACHIKO AG SF -01 belongs to the Energy sector and operates in the industry.
What is ACHIKO AG SF -01 (4ZI) current stock price?
As of the latest data, ACHIKO AG SF -01 stock price is €0.45, with a previous close of €0.45.
What is ACHIKO AG SF -01 (4ZI) current market capitalization?
ACHIKO AG SF -01 market cap is approximately 65.32 million.
What is ACHIKO AG SF -01 (4ZI) Earnings Per Share (EPS)?
The trailing EPS is -€0.07.
Does ACHIKO AG SF -01 (4ZI) pay dividends?
No. ACHIKO AG SF -01 does not pay a dividend.
What is ACHIKO AG SF -01 (4ZI) beta (volatility) score?
ACHIKO AG SF -01 has a beta of -0.392, indicating lower volatility than the overall market.
